InvestorsHub Logo
icon url

Dieselpro

05/24/21 10:53 AM

#167406 RE: that_little_voice #167398

All of this is irrelevant from an investment standpoint with CYDY. The number of covid-19 cases won't stop approval for Leronlimab. After Leronlimab receives first approval it will stabilize CytoDyn as a pharma company and start revenue. COVID-19 will be here indefinitely and approval for Leronlimab will open the door for other ARDS.